Low-dose methotrexate as rescue therapy in patients with hidradenitis suppurativa and pyoderma gangrenosum developing human antichimeric antibodies to infliximab: A retrospective chart review - 09/01/20
Doi : 10.1016/j.jaad.2019.09.012
Leo L. Wang, PhD, MS a, Robert G. Micheletti, MD b, ⁎ 
a Perelman School of Medicine, University of Pennsylvania, Philadelphia
b Departments of Dermatology and Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia
∗Correspondence to: Robert G. Micheletti, MD, 3400 Civic Center Blvd, Perelman Center for Advanced Medicine, Room 724, Philadelphia, PA 191043400 Civic Center BlvdPerelman Center for Advanced Medicine, Room 724PhiladelphiaPA19104
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Reviewed and approved by the IRB of the University of Pennsylvania (822890). |
|
| Reprints not available from the authors. |
© 2019
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 82 - N° 2
P. 507-510 - février 2020 Retour au numéro
Article précédent
- Nonmelanoma skin cancers are more likely to be untreated in elderly patients
- Pallavi Basu, Ashley Beckles, Martina L. Porter, Suzanne Olbricht
- Characterizing inpatient hospitalizations for hidradenitis suppurativa in the United States
- Laura Anzaldi, Jamilah A. Perkins, Angel S. Byrd, Hadi Kharrazi, Ginette A. Okoye
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?